AVAH:NSD-Aveanna Healthcare Holdings Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 2.14

Change

+0.02 (+0.94)%

Market Cap

USD 0.41B

Volume

0.28M

Avg Analyst Target

USD 5.48 (+156.28%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


AVAH Stock Forecast & Price:
Based on the Aveanna Healthcare Holdings Inc stock forecasts from 10 analysts, the average analyst target price for Aveanna Healthcare Holdings Inc is USD 5.48 over the next 12 months. Aveanna Healthcare Holdings Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Aveanna Healthcare Holdings Inc is Slightly Bearish, which is based on 3 positive signals and 7 negative signals. At the last closing, Aveanna Healthcare Holdings Inc’s stock price was USD 2.14. Aveanna Healthcare Holdings Inc’s stock price has changed by -4.04% over the past week, -14.06% over the past month and -78.60% over the last year.

About Aveanna Healthcare Holdings Inc (AVAH:NSD)

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows p ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-12 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ACHC Acadia Healthcare Company Inc

+1.20 (+1.47%)

USD7.50B 26.56 16.08
LHCG LHC Group

+0.76 (+0.47%)

USD5.07B 68.62 29.81
ENSG The Ensign Group Inc

+1.73 (+2.01%)

USD4.76B 23.99 17.63
AMED Amedisys Inc

-0.09 (-0.07%)

USD3.97B 27.96 16.20
SGRY Surgery Partners Inc

+0.53 (+1.43%)

USD3.34B 63.00 14.33
AMEH Apollo Medical Holdings Inc

+0.18 (+0.36%)

USD2.39B 33.09 79.94
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
TVTY Tivity Health Inc

N/A

USD1.62B 19.06 12.00
ADUS Addus HomeCare Corporation

+1.22 (+1.31%)

USD1.52B 34.08 19.95
HCSG Healthcare Services Group Inc

+0.39 (+2.70%)

USD1.04B 36.05 17.22

ETFs Containing AVAH

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -71.08% 5% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -71.08% 5% F 11% F
Trailing 12 Months  
Capital Gain -77.45% 11% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -77.45% 11% F 13% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -16.65% 25% F 15% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.65% 20% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 31.79% 80% B- 52% F
Risk Adjusted Return -52.38% 25% F 17% F
Market Capitalization 0.41B 36% F 54% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 0.61 95% A 91% A-
Price / Cash Flow Ratio -36.46 82% B- 85% B
EV/EBITDA 115.60 5% F 2% F
Management Effectiveness  
Return on Equity -20.71% 32% F 37% F
Return on Invested Capital -2.39% 43% F 44% F
Return on Assets 2.87% 45% F 72% C-
Debt to Equity Ratio 192.90% 11% F 11% F
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 5.45 59% F 32% F
Short Percent 4.81% 64% D 35% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.